Pleural effusion cytology is already used in cancer diagnosis, especially in metastatic settings, but its sensitivity can be limited.

The field of lung cancer research has increasingly turned its attention to the tumor immune microenvironment (TIME) in non-small cell lung cancer (NSCLC), ...

One of the biggest challenges in cancer research is understanding why some tumor cells become especially aggressive, invasive ...

Scientists have found a way to supercharge lung cancer treatment by transplanting healthy mitochondria into tumors, which both boosts immune response and makes chemotherapy far more effective. By ...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest ...

Trudy Oliver, professor of pharmacology and cancer biology, is part of a team of scientists that recently published a study uncovering a major shift in how scientists understand small-cell lung cancer ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A nanobody-based technology can precisely identify and attack lung cancer cells—sparing surrounding healthy tissue. This ...

HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...

Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer progression and patient health. Stage 1 focuses on tumor removal, Stage 2 ...